ℹ️
🇬🇧
Search
Search for publications relevant for "T-cell non-Hodgkin lymphoma"
T-cell non-Hodgkin lymphoma
Publication
Class
Person
Publication
Programmes
Export current view
publication
The role of protein p27kip1 in the cell cycle and its staining patterns in lymphoid tissues, especially in B-cell non-Hodgkin lymphomas (a review)
2003 |
Faculty of Medicine in Pilsen
publication
The role of protein p27kip1 in the cell cycle and its staining patterns in lymphoid tissues, especially in B-cell non-Hodgkin lymphomas (a review)
2003 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas
2020 |
First Faculty of Medicine
publication
Fatal course of zygomycosis in a patient treated for diffuse large B-cell non-Hodgkin lymphoma
2009 |
Second Faculty of Medicine
publication
Final report of University Hospital Hradec Kralove to the clinical trial protocol no. PIX306
Publication without faculty affiliation
publication
Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia
2010 |
Second Faculty of Medicine
publication
Treatment of pediatric B-cell non-Hodgkin's lymphomas at the Motol Hospital in Prague, Czech Republic: Results based on the NHL BFM 90 protocols
1999 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma
2013 |
Second Faculty of Medicine, Third Faculty of Medicine
publication
Ibrutinib plus RICE/RVICI for R/R mature B-NHL in children/young adults: SPARKLE trial
2023 |
Second Faculty of Medicine
publication
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial
2015 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Pixantrone plus rituximab versus gemcitabine plus rituximab in patients with relapsed aggressive B-cell non-Hodgkin lymphoma not eligible for stem cell transplantation: a phase 3, randomized, multicentre trial (PIX306)
2020 |
Faculty of Medicine in Hradec Králové
publication
Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma
2009 |
Second Faculty of Medicine
publication
Treatment of relapsed and refractory Hodgkin lymphoma
2010 |
Third Faculty of Medicine
publication
Salvage Treatment and the Role of Transplantation in Lymphomas
2015 |
First Faculty of Medicine
publication
Comment on study
2018 |
Faculty of Medicine in Hradec Králové
publication
The current role of haematopoietic stem cell transplantation in the treatment of lymphomas : review
2010 |
First Faculty of Medicine
publication
Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study
2015 |
Faculty of Medicine in Hradec Králové
publication
Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model
2016 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Pixantrone-rituximab versus gemcitabine-rituximab in relapsed/refractory aggressive non-Hodgkin lymphoma
2016 |
Faculty of Medicine in Hradec Králové
publication
Ibrutinib plus CIT for R/R mature B-NHL in children (SPARKLE trial): initial safety, pharmacokinetics, and efficacy
2020 |
Second Faculty of Medicine
publication
Yescarta - new hope for patients with relapsed diffuse large-cell lymphoma?
2019 |
First Faculty of Medicine
publication
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma
2021 |
First Faculty of Medicine
publication
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
2020 |
First Faculty of Medicine
publication
Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma
2008 |
Second Faculty of Medicine
publication
Non-Hodgkin's B-lymphoma of the ovaries with an unfavourable prognosis - incidental finding during caesarean section
2018 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Mantle cell lymphoma: insights into therapeutic targets at the preclinical level
2020 |
First Faculty of Medicine
publication
Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein
2007 |
Second Faculty of Medicine
publication
Impact of Fc gamma-receptor polymorphisms on the response to rituximab treatment in children and adolescents with mature B cell lymphoma/leukemia
2016 |
Second Faculty of Medicine
publication
Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma
2019 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas
2022 |
First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Mathematics and Physics